SINDU PHARMACEUTICALS
DEAD

Serial Number

78638080

Owner

IndUS Pharmaceuticals, Inc.

Attorney

Jeffrey D. Hsi

Filing Date

May 26, 2005

Add to watchlist:

No watchlists yet
View on USPTO

SINDU PHARMACEUTICALS Trademark

Serial Number: 78638080

SINDU PHARMACEUTICALS is a trademark filed by IndUS Pharmaceuticals, Inc. on May 26, 2005. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

IndUS Pharmaceuticals, Inc. (2 trademarks)

27 Jenkins Road
Andover, MA 01810

Entity Type: 03

Trademark Details

Filing Date

May 26, 2005

Registration Date

Not Registered

Published for Opposition

February 14, 2006

Goods & Services

pharmaceutical products intended for the treatment of infectious diseases, namely, bacterial, fungal, parasitic and viral infections, neoplastic disorders namely, hematologic cancer disorders and solid tumors, autoimmune disorders, namely, diabetes, arthritis, psoriasis, bone marrow and organ transplantation and immunosuppression, metabolic disorders namely, obesity and atherosclerosis, cardiovascular disorders namely, hypertension, congestive heart failure, myocardial infarction, angina and vascular diseases, renal disorders namely, acute and chronic renal failure and urinary disorders affecting renal conservation of water, central nervous system disorders namely, analgesia, anesthesia, hypnotics, sedatives, anxiety, psychosis, depression, mania, epilepsies, migraine, neurodegeneration, and drug addiction, inflammatory disorders namely, asthma, gout, inflammatory bowel disease, rheumatoid arthritis, gastrointestinal disorders namely, ulcers, emesis, diarrhea, irritable bowel syndrome, hormonal disorders affecting the thyroid, estrogens, progestins, androgens, glucocorticoids, insulin and glucose regulation, calcification and bone turnover, dermatological and opthalmological disorders

pharmaceutical drug development services of pharmaceutical products intended for the treatment of infectious diseases, namely, bacterial, fungal, parasitic and viral infections, neoplastic disorders namely, hematologic cancer disorders and solid tumors, autoimmune disorders, namely, diabetes, arthritis, psoriasis, bone marrow and organ transplantation and immunosuppression, metabolic disorders namely, obesity and atherosclerosis, cardiovascular disorders namely, hypertension, congestive heart failure, myocardial infarction, angina and vascular diseases, renal disorders namely, acute and chronic renal failure and urinary disorders affecting renal conservation of water, central nervous system disorders namely, analgesia, anesthesia, hypnotics, sedatives, anxiety, psychosis, depression, mania, epilepsies, migraine, neurodegeneration, and drug addiction, inflammatory disorders namely, asthma, gout, inflammatory bowel disease, rheumatoid arthritis, gastrointestinal disorders namely, ulcers, emesis, diarrhea, irritable bowel syndrome, hormonal disorders affecting the thyroid, estrogens, progestins, androgens, glucocorticoids, insulin and glucose regulation, calcification and bone turnover, dermatological and opthalmological disorders

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jun 8, 2009 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 8, 2009 ABN6
SOU EXTENSION 5 GRANTED
Nov 7, 2008 EX5G
SOU EXTENSION 5 FILED
Nov 7, 2008 EXT5
SOU TEAS EXTENSION RECEIVED
Nov 7, 2008 EEXT
SOU EXTENSION 4 GRANTED
May 9, 2008 EX4G
SOU EXTENSION 4 FILED
May 9, 2008 EXT4
SOU TEAS EXTENSION RECEIVED
May 9, 2008 EEXT
SOU EXTENSION 3 GRANTED
Nov 6, 2007 EX3G
SOU EXTENSION 3 FILED
Nov 6, 2007 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 6, 2007 EEXT
SOU EXTENSION 2 GRANTED
Apr 26, 2007 EX2G
SOU EXTENSION 2 FILED
Apr 26, 2007 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 26, 2007 EEXT
SOU EXTENSION 1 GRANTED
Nov 9, 2006 EX1G
SOU EXTENSION 1 FILED
Nov 9, 2006 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 9, 2006 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
May 9, 2006 NOAM
PUBLISHED FOR OPPOSITION
Feb 14, 2006 PUBO
NOTICE OF PUBLICATION
Jan 25, 2006 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 4, 2006 PREV
ASSIGNED TO LIE
Dec 30, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 20, 2005 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 20, 2005 XAEC
EXAMINERS AMENDMENT E-MAILED
Dec 20, 2005 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 20, 2005 CNEA
ASSIGNED TO EXAMINER
Dec 19, 2005 DOCK
NEW APPLICATION ENTERED
Jun 6, 2005 NWAP